Tybourne Capital Management

Latest statistics and disclosures from Tybourne Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are TSHA, FBRX, ALMS, ZNTL, and represent 100.00% of Tybourne Capital Management's stock portfolio.
  • Reduced shares in these 4 stocks: BCYC (-$6.9M), MBUU, TSHA, ZNTL.
  • Sold out of its positions in BCYC, MBUU.
  • Tybourne Capital Management was a net seller of stock by $-11M.
  • Tybourne Capital Management has $31M in assets under management (AUM), dropping by -10.44%.
  • Central Index Key (CIK): 0001553936

Tip: Access up to 7 years of quarterly data

Positions held by Tybourne Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Tybourne Capital Management

Tybourne Capital Management holds 4 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Taysha Gene Therapies Com Shs (TSHA) 39.1 $12M -9% 3.7M 3.27
 View chart
Forte Biosciences Com New (FBRX) 38.1 $12M 787k 15.00
 View chart
Alumis (ALMS) 18.0 $5.6M 1.4M 3.99
 View chart
Zentalis Pharmaceuticals (ZNTL) 4.7 $1.5M -34% 962k 1.51
 View chart

Past Filings by Tybourne Capital Management

SEC 13F filings are viewable for Tybourne Capital Management going back to 2012

View all past filings